Assessing venous thromboembolism risk in lung cancer: a comprehensive evaluation of the khorana score, clinical characteristics, and incidence of thrombosis

IntroductionVenous thromboembolism (VTE) occurrence in patients with lung cancer is associated with significant morbidity and mortality. The Khorana Score (KRS) is a validated risk stratification tool developed to estimate risk of VTE in patients with cancer that incorporates clinical and laboratory...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Sean C. Dougherty, Rishika Singh, Caleb McKinney, Aditya Singh, Jack Masur, Alia C. Lynch, Ryan D. Gentzler, Wendy Novicoff, Nathan Roberts, Richard D. Hall
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2026-01-01
Σειρά:	Frontiers in Oncology
Θέματα:	khorana risk score non-small cell lung cancer oncogenic driver mutation small cell lung cancer venous thromboembolism
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1651192/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!